Nucleo CMP Forte for moderate to severe brain injury in children
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial studies whether a supplement called Nucleo CMP Forte can improve outcomes after a moderate or severe traumatic brain injury in children. It may help families see if adding this treatment makes recovery better and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a child (pediatric age group) with a traumatic brain injury
- Your injury is described as moderate or severe
- You do not have an underlying brain or nervous system disorder (a separate condition affecting the central nervous system)
- Your doctors determine the injury severity using their usual medical assessments
- You are able to follow the study’s visit and treatment schedule as required by the trial team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children and young adults who have brain damage from a severe head injury or lack of oxygen at birth. It aims to learn more about these conditions and how to help patients.
This study tests whether memantine, a medicine usually used for memory problems, can help people recover from mild to moderate traumatic brain injury. You would receive memantine along with your standard care, starting within 24 hours of the injury.
This study tests whether giving creatine, a natural supplement, can help children recover function after a moderate-to-severe brain injury. It may support brain energy and improve recovery.
This trial tests a treatment for brain injury in premature babies born before 32 weeks. It aims to protect and repair white matter, the part of the brain that helps nerve cells communicate.
This trial tests whether a medicine called memantine can help the brain heal after a mild or moderate head injury. It aims to improve recovery by protecting brain blood vessels and nerve cells.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue can help calm inflammation in the brain after severe traumatic brain injury. It is for patients aged 18–50 who need brain pressure monitoring and are not responding to verbal commands 5 days after sedation is stopped.
Hear when a new Brain Injuries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.